Publications by authors named "Josef Meingassner"

Claim this Profile
D
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases.
David A Sandham, Nicola Arnold, Heinrich Aschauer, Kamlesh Bala, Lucy Barker, Josef Meingassner

Bioorg Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of stearoyl CoA desaturase in the skin induces atrophy of the sebaceous glands.
Josef G Meingassner, Heinrich Aschauer, Anthony P Winiski, Natalie Dales, David Yowe

J Invest Dermatol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.
Jens-Michael Jensen, Kerstin Ahrens, Josef Meingassner, Andreas Scherer, Matthias Bräutigam

Exp Dermatol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.
Hans Skvara, Frank Kalthoff, Josef G Meingassner, Barbara Wolff-Winiski, Heinrich Aschauer

J Invest Dermatol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14.
Kerstin Ahrens, Michael Schunck, Graziella-Francesca Podda, Josef Meingassner, Anton Stuetz

J Invest Dermatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of corticosteroids and pimecrolimus on the developing skin immune system in humans and mice.
Simone Meindl, Christine Vaculik, Josef G Meingassner, Gero Kramer, Johnnie Akgün

J Invest Dermatol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity.
Tina Rubic, Günther Lametschwandtner, Sandra Jost, Sonja Hinteregger, Julia Kund, Josef G Meingassner

Nat Immunol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.
Hans Skvara, Markus Dawid, Elise Kleyn, Barbara Wolff, Josef G Meingassner

J Clin Invest· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor.
Cornelia Halin, Hermann Fahrngruber, Josef G Meingassner, Guido Bold, Amanda Littlewood-Evans

Am J Pathol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice.
Christine Graf, Barbara Zemann, Philipp Rovina, Nicole Urtz, Andrea Schanzer, Josef G Meingassner

J Immunol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal transducer and activator of transcription 1 decoy oligodeoxynucleotide suppression of contact hypersensitivity.
Andreas H Wagner, Inka Wittjen, Tomislav Stojanovic, Peter Middel, Josef G Meingassner

J Allergy Clin Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
Martin A Schneider, Josef G Meingassner, Martin Lipp, Henrietta D Moore, Antal Rot

J Exp Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
Anton Stuetz, Karl Baumann, Maximilian Grassberger, Klaus Wolff, Josef G Meingassner

Int Arch Allergy Immunol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palisade endings in extraocular muscles of the monkey are immunoreactive for choline acetyltransferase and vesicular acetylcholine transporter.
Kadriye Zeynep Konakci, Johannes Streicher, Wolfram Hoetzenecker, Ines Haberl, Michael Josef Franz Blumer, Josef Gottfried Meingassner

Invest Ophthalmol Vis Sci· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin.
Josef G Meingassner, Heinrich Aschauer, Anton Stuetz, Andreas Billich

Exp Dermatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
Barbara Nell, Ingo Walde, Andreas Billich, Peter Vit, Josef G Meingassner

Vet Ophthalmol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases.
Andreas Billich, Josef G Meingassner, Peter Nussbaumer, Sandrine Desrayaud, Charles Lam

J Steroid Biochem Mol Biol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.
Meenakshi S Venkatraman, Amar Chittiboyina, Josef Meingassner, Christopher I Ho, James Varani

Arch Dermatol Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo.
Dieter Scholz, Karl Baumann, Max Grassberger, Barbara Wolff-Winiski, Grety Rihs, Josef G Meingassner

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
Thomas Ullrich, Karl Baumann, Karl Welzenbach, Simone Schmutz, Gian Camenisch, Josef G Meingassner

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells.
Wolfram Hoetzenecker, Josef G Meingassner, Rupert Ecker, Georg Stingl, Anton Stuetz

J Invest Dermatol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis.
Jesús Medina, Valérie Picarles, Brigitte Greiner, Christian Elsaesser, Maryelle Kolopp, Josef Meingassner

Biochem Pharmacol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A.
Josef G Meingassner, Hermann Fahrngruber, Assadollah Bavandi

J Invest Dermatol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis